Topic: research

The Omicum Gallery has exhibited art since the building was completed in 2012. The continuous exhibition of art began in the winter of 2017-2018 when Sulev Kuuse started to curate the exhibitions.

Priit Väljamäe, Associate Professor of General and Microbial Biochemistry at the Institute of Molecular and Cell Biology, University of Tartu, was awarded a research prize of 20,000 euros. The Estonian government confirmed this year's state research award laureates. Seven researchers from the University of Tartu received the annual award for the best research completed and published in the previous four years.:

The aim of the national contest for university students is to promote research among university students, stimulate them to be more active and to acknowledge students who have achieved outstanding results with their thesis, study, research or scientific publication. The deadline for submitting research papers was 15 September 2021. The award fund is 83 977,79 euros in total:

Structural polysaccharides – cellulose and chitin – are the most abundant polysaccharides on the Earth and represent a huge reservoir of renewable carbon.

Mitochondria are organelles that have their own genomic DNA. We are interested in the mechanisms by which the mitochondrial genome is propagated during the cell cycle.

Our research is focused on the response of microbial communities to anthropogenic and natural stressors in different environments. One of the main goals of our research is to determine the key microbial species and metabolic pathways responsible for the degradation of various hydrocarbon compounds of oil in different marine compartments (aerobic and anaerobic water, sediments and shoreline) of the Baltic Sea and Arctic marine environments.

We are interested on the fundamental aspects of protein biosynthesis. In this respect we use E. coli as a model system. We study functional topography of the bacterial ribosome. In addition, we analyz

. Mitochondrion is best known as the major site of ATP synthesis, but it is also involved in many other metabolic processes, e.g. synthesizing a number of metabolites that are important for various cellular processes.

In the current project, we aim to uncover the role of aryl hydrocarbon receptor (AHR) in pancreatic ductal adenocarcinoma (PDAC). We test the hypothesis that inhibition of AHR activity with specific inhibitors has a potent therapeutic value in PDAC treatment. It is also important to mention that inhibition of AHR activity has great potential to boost the efficacy of cancer immunotherapy. Together with our project partners, we will develop and test novel AHR inhibitors in preclinical experiments.

We are using efficient expression systems to produce heterologous proteins from pro- and eukaryotic organisms in Escherichia coli. We have expressed glucoside hydrolases (e.g. levansucrases, α-glucosi